Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

2014 ACR/ARHP Annual Meeting: Patient-Centered Outcomes Research Gaining Support

Kathy Holliman  |  Issue: January 2015  |  January 1, 2015

Outcomes Research Gaining Support

BOSTON—The Patient-Centered Outcomes Research Institute (PCORI) has supported more than a dozen musculoskeletal disease research projects since it began funding research in 2012, studies that consider the patients’ needs and preferences and focus on outcomes that are important to patients. The importance of including patients as partners in research was the topic of a preconference session, ACR Clinical Research Conference: Patient-Centered Outcomes in Rheumatology, on Nov. 14 at the ACR/ARHP Annual Meeting.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Sherine E. Gabriel, MD, MSc, at Mayo Medical School, Rochester, Minn., and founding chair of the PCORI methodology committee, said that PCORI “pays special attention to conditions that heavily burden patients, the public, families and the healthcare system.” PCORI considers for funding those projects that emphasize the expectations that patients have about treatment options, the harms and benefits of options, and other therapy considerations that actually matter to patients in the real world.

The main focus of PCORI is comparative clinical effectiveness research (CER), and the projects it supports must use patient-centered outcomes research methods. This type of research seeks to address the questions that patients and their doctors have about treatment options and the outcomes of treatment. PCORI is committed to providing patients with information about which treatment choices may work best for them depending on that patient’s values, circumstances and preferences.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

PCORI considers projects that are initiated by investigators who intend to include patients and other stakeholders throughout the research design and dissemination of the results. Patients and stakeholders can also seek funding for topic-specific proposals that will potentially impact practice and patient outcomes. The institute’s 47 methodology standards, which highlight the importance of using appropriate methods in patient-centered research, are intended to help the applicants craft their research questions, Dr. Gabriel said.

PCORI Executive Director Joe Selby, MD, MPH, said PCORI has supported the development of the National Patient-Centered Clinical Research Network (PCORnet), a large, representative, national network for conducting clinical outcomes research that brings participants access to information.

PCORnet is intended to be a “network of networks,” a secure network that can improve the speed, efficiency and use of patient-centered comparative effectiveness research. PCORI approved $93.5 million last year to support 29 clinical research data networks that together will provide access to diverse, nationally representative health information to support study designs.

PCORnet will integrate data from 11 Clinical Data Research Networks (CDRNs), which originate in healthcare systems, such as hospitals, health plans or practice-based networks. These networks collect real-time data during patient care. PCORI is also supporting 18 Patient-Powered Research Networks (PPRNs), which are operated and governed by groups of patients and their partners who are focused on a particular condition and are interested in participating in research and sharing their own health information.

Leslie Kelly-Hall, senior vice president of policy at Healthwise, a nonprofit provider of health information and decision support tools, emphasized during the session the importance of collaboration between patients and their healthcare providers in medical decision making. Not involving patients, she said, leads to over- or undertreatment, misunderstandings and “missed opportunities for relationship.” Patients want shared decision making and choices, “including doing nothing,” she said.

Dr. Selby agreed. Patients and other stakeholders should be involved in topic selection and research prioritization, proposal review, design and conduct of research, dissemination and implementation of results, he said. “Patients bring a lived experience of a condition, disease or suboptimal care,” he said.

Moving Beyond the Old-School Approach

Karon Cook, PhD, at the Feinberg School of Medicine at Northwestern University in Evanston, Ill., compared the “old-school approach” of research with methods now being used in patient-reported outcomes research. The NIH-sponsored Patient Reported Outcomes Measurement Information System (PROMIS) is a “great prototype” that identifies outcomes that cut across a range of diseases, she said. More than $110 million was spent to develop the program, and it “has radically changed how patient-reported outcomes are measured,” she added.

PROMIS uses modern measurement theory to assess patient-reported health status and reliably measures those outcomes for both clinical research and practice. Its computer software, called Computer Adaptive Testing (CAT), has combined the advancements in measurement theory with technology so that a patient’s responses to previous questions lead to automatic selection of the next questions the patient is asked. The patient is therefore queried on a minimal number of questions, but there is no loss in measurement precision. In one example, use of CAT required only 16% to 22% of time to complete compared with the time required to complete a “legacy measurement,” Dr. Cook said.

Collaborative Networks of Patient Data

In his presentation about PCOR and patients as partners in research, Jeffrey R. Curtis, MD, MPH, MS, at University of Alabama at Birmingham, noted that $500 million to $800 million is required to develop a drug from bench to bedside, with most drug trials not finishing on time and only about 6% of physicians participating in the trials. “Not all questions can be answered or should be answered by traditional clinical trials, which are typically expensive and inefficient,” he said.

According to Dr. Curtis, using a network like PCORnet or registry data can provide substantial cost savings for data collection, enhanced outcome assessment, more drug exposure information and information about hospitalizations, emergency department visits and outpatient care.

As an example, Dr. Curtis described his involvement in a large pragmatic trial about the live herpes zoster vaccine in RA patients using TNF therapy. The researchers used data from Medicare combined with data from the Consortium of Rheumatology Researchers of North America (CORRONA) disease registry to determine whether it was feasible to recruit 4,000 patients and to help select sites for the research. As a result, more than 12,000 potentially eligible patients were identified from the 50 largest rheumatology practices.1

A registry, such as CORRONA, “already has the data to answer a research question,” he said.


Kathy L. Holliman, MEd, is a medical writer based in Beverly, Mass.

References

  1. Curtis JR, Wright NC, Xie F, et al. Use of health plan combined with registry data to predict clinical trial recruitment. Clin Trials. 2014;11(1):96–101.

Page: 1 2 3 | Multi-Page
Share: 

Filed under:Meeting ReportsResearch Rheum Tagged with:2014 ACR/ARHP Annual MeetingFundingHollimanoutcomepatient carePCORIResearchrheumatology

Related Articles

    Gabriel to Chair Healthcare Reform Panel

    April 13, 2011

    Former ACR president assigned key role in transforming nation’s healthcare system

    Tips for Engaging Your Pediatric Research Patients

    January 17, 2020

    ATLANTA—Around 2002, when Vincent Del Gaizo’s son was just 15 months old, he was hospitalized in an intensive care unit and, weeks later, was diagnosed with systemic juvenile idiopathic arthritis (JIA). “We had the same 8 trillion questions that all parents have when their child is diagnosed with a condition you’ve never heard of: ‘Is…

    Patient-Centered Care Model for RA Flares Could Improve Self-Management of Symptoms

    December 16, 2015

    Image Credit: lzf/shutterstock.com Having a better way to measure flares would help patients know ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEhow to better manage their flares, improving their quality of life. ad goes here:advert-2ADVERTISEMENTSCROLL TO CONTINUEA recent trend to incorporate patient-reported outcomes (PROs) in clinical research, and ultimately clinical practice, is a response to the need to…

    The Future of Pediatric Rheumatology Grounded in Evolution of Childhood Arthritis and Rheumatology Research Alliance

    December 15, 2016

    Pediatric rheumatology was formally recognized as a specialty in 1991 by the American Board of Pediatrics. Yukiko Kimura, MD Pediatric rheumatology was formally recognized as a specialty in 1991 by the American Board of Pediatrics. Prior to this time, children with rheumatic diseases were treated by a hodgepodge of providers. In addition to providers who…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences